Spectrum Asset Management (California)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-33,361
Closed -$2.49M 92
2020
Q1
$2.49M Buy
33,361
+430
+1% +$29.7K 2.38% 10
2019
Q4
$2.14M Buy
32,931
+4,205
+15% +$274K 1.18% 27
2019
Q3
$1.82M Buy
28,726
+607
+2% +$39.7K 1.17% 24
2019
Q2
$1.9M Hold
28,119
1.19% 26
2019
Q1
$1.83M Buy
28,119
+3,120
+12% +$207K 1.23% 19
2018
Q4
$1.56M Sell
24,999
-300
-1% -$21K 1.24% 20
2018
Q3
$1.95M Buy
25,299
+22,475
+796% +$1.7M 1.16% 17
2018
Q2
$200K Hold
2,824
0.18% 63
2018
Q1
$204K Sell
2,824
-600
-18% -$47.7K 0.18% 66
2017
Q4
$245K Buy
3,424
+424
+14% +$32.2K 0.19% 70
2017
Q3
$243K Buy
+3,000
New +$229K 0.21% 63

Other funds holding GILD

Spectrum Asset Management (California)'s GILD Position: Q2 2020 in Review

Spectrum Asset Management (California) sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 33,361 shares — an estimated $2.49M sold.

Spectrum Asset Management (California) first reported a position in GILD in Q3 2017 and held it in 11 quarters. The position peaked at $2.49M in Q1 2020. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Spectrum Asset Management (California) reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Spectrum Asset Management (California) sold 33,361 Gilead Sciences shares in Q2 2020, an estimated $2.49M.
  • Spectrum Asset Management (California) first reported a position in Gilead Sciences in Q3 2017 and held it in 11 quarters.
  • Spectrum Asset Management (California)'s Gilead Sciences position peaked at $2.49M in Q1 2020.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Spectrum Asset Management (California)'s 13F filing for Q2 2020, filed 22 Jul 2020.